SVP, GM Life Sciences
As SVP and GM of Life Sciences, Kara is responsible for spearheading the Company’s new business division, leading the development of new offerings to provide insight for biopharmaceutical companies as they develop and market new therapies and treatments.
Prior to Clarify, I was Managing Director of Mobile Health at Medidata Solutions, an industry-leading provider of SaaS solutions to the Life Sciences R&D industry. I led the creation of a comprehensive offering in mobile health, secured charter clients for offering development and launch, and built up a team to deliver and scale the offering. My BU lead the acquisition of a complementary cloud software company in 2017, and my client base grew to encompass several top-10 pharmaceutical companies and over a dozen in the top 50, in addition to biotech and medical device organizations.
Before Medidata, I spent four years in McKinsey’s healthcare practice, and subsequently worked in corporate development for Ikaria, a private-equity backed biotech since acquired by Mallinckrodt.
I have spoken widely on patient engagement in clinical trials and the use of wearables to gather objective clinical data, including at SXSW, DIA (Drug Industry Association), Disruptive Innovations in Pharma, Mobile Clinical Trials Congress, and Data Quality & Technology in Clinical Trials. I have been interviewed by Bloomberg, NPR, Clinical Leader, The Street, MobiHealthNews, Applied Clinical Trials, PharmaVOICE, Pharmaceutical Technology, International Clinical Trials, and many other publications, and I recorded a Tech Tonics podcast in 2016. I was named to the PharmaVOICE 100 in 2015 and was highlighted as a Healthcare Businesswomen’s Association Rising Star that same year. I hold an MBA from Harvard Business School and a BA from Yale University.